Search for: "Pfizer Corporation" Results 741 - 760 of 818
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2008, 7:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WIPO Copyright Committee 16th session to discuss Broadcast Treaty, new proposal for exceptions and limitations agreement: (Public Knowledge), (Public Knowledge), (Intellectual Property Watch), (Public Knowledge), (Public Knowledge), (IPwar’s), (Intellectual Property Watch), (KEI), (Public Knowledge), (IP Justice), (IP Justice), (KEI), (KEI),… [read post]
11 Mar 2008, 9:36 am
See Bias of Eli Kintisch shows in "Small Win for Wisconsin in Stem Cell Fight " Kintisch article in Science challenged in Sept. 06 JPTOS Looking back on the PubPat challenge to the WARF patents PubPat, FTCR lose in inter partes re-exam of WARF stem cell patent**Recall -->Gadfly buzzing around big-name corporate patentsBy Eli Kintisch, FT.com sitePublished: Aug 29, 2005 In June, the US Patent and Trademark Office ruled that Pfizer's patent for Lipitor, a… [read post]
7 Mar 2008, 10:06 am
Peter Rost formerly of Pfizer or Cynthia Cooper formerly of Worldcom. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
6 Mar 2008, 6:00 am
Of course, whether reliance and causation are elements of a UCL claim is an unresolved question that the Supreme Court is expected to address in In re Tobacco and Pfizer. [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office releases… [read post]
22 Feb 2008, 6:00 pm
: (Patent Baristas),Vietnam : new developments in patent protection for medical uses: (Patent Docs),Wisconsin Alumni Research Foundation licenses stem cell patents to BioTime: (IPBiz)Pharma & Biotech - ProductsFloxin (Ofloxacin) –US Supreme Court declines Daiichi Sankyo’s request for appeal of CAFC decision reversing Daichii’s initial win in its ofloxacin patent infringement case against Apotex: (IP Law360),Galvus (Vildagliptin) – Indian patent granted… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
14 Feb 2008, 2:23 pm
I’ve been giving some thought to the dust up last year between Marty Lipton and other governance experts as to whether Pfizer’s initiative of having several of its independent directors meet with its largest institutional investors represented a landmark in the decline of director-centric corporate governance, and have also been thinking about what we mean when we talk about director-centric vs. shareholder-centric governance. [read post]
8 Feb 2008, 4:02 pm
The Pfizer Corporation played a key role instigating the New London, Connecticut condemnations that led to the Kelo case. [read post]
6 Feb 2008, 12:39 am
Pfizer and Verizon are current sponsors but EDI seeks additional sponsors. [read post]
17 Jan 2008, 10:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:The European antitrust raids on Pfizer, AstraZeneca, Glaxo, Sanofi-Aventis: (IP Law360), (Wall Street Journal Health Blog), (IAM), (IPEG), (SmartBrief), (In the pipeline),Hasbro and Mattel alleged trade mark infringement and demand shut down of Scrabulous, a free online gaming site allowing users to play a version of… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of… [read post]
7 Jan 2008, 6:18 am
And Pfizer has now seen its trial loss erased by entry of judgment notwithstanding the verdict. [read post]
7 Jan 2008, 6:18 am
And Pfizer has now seen its trial loss erased by entry of judgment notwithstanding the verdict. [read post]
5 Jan 2008, 6:22 pm
But shouldnâ € ™t someone point out that Mark Penn, chief Hillary strategist, is also CEO of Burson-Marsteller, the PR firm for Wyeth, Pfizer, Amgen and hundreds of other corporations? [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
3 Jan 2008, 8:39 pm
Internal Corporate Use But it's not all about connecting in the conventional sense. [read post]